Foghorn Therapeutics, Inc. (FHTX)
5.73
-0.10
(-1.72%)
USD |
NASDAQ |
Feb 20, 16:00
5.73
0.00 (0.00%)
After-Hours: 20:00
Foghorn Therapeutics Total Assets (Quarterly) : 204.96M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Eli Lilly & Co. | 112.48B |
| Halozyme Therapeutics, Inc. | 2.714B |
| Vertex Pharmaceuticals, Inc. | 26.14B |
| Fortress Biotech, Inc. | 181.41M |
| Oramed Pharmaceuticals, Inc. | 220.49M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 294.62M |
| Shareholders Equity (Quarterly) | -89.66M |
| Debt to Equity Ratio | -0.2513 |
| Current Ratio | 2.164 |
| Net Debt Paydown Yield | 1.33% |